Patient case activity: Refractory migraine attacks

Nada Hindiyeh presents a patient with refractory migraine attacks and advises on the optimum individualized therapeutic course.

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. NACCME designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was launched on March 4, 2021. The data were correct at time of publication and no further updates have been made to the content

Learning objectives

After taking part in this case study, you will be able to:

  • Describe how to identify and classify refractory migraine attacks.
  • Utilize best practice recommendations to tailor treatment for patients with refractory attacks and understand where novel therapeutics may benefit the acute treatment plan.

Nada Hindiyeh

Login or create a free account to access this activity

Create a Free Account

Already Registered? Login Here

Scroll to Top

Nada Hindiyeh

Nada Hindiyeh is a board certified Neurologist and headache specialist and is currently a Clinical Assistant Professor in the department of Neurology at Stanford University. She is the Director of Clinical Research for the Stanford division of Headache Medicine and serves as principal investigator for several clinical trials.

Dr Hindiyeh was awarded the 2013 Clinical Research Fellowship in Neurotoxins by the American Academy of Neurology and under this scholarship is currently investigating a diagnostic screening protocol for chronic migraine. Other research interests include pathophysiology and novel treatments for migraine, the use of transcranial magnetic stimulation in headache disorders, and participation in clinical trials for new headache therapeutics. She is currently a member of the American Headache Society (AHS), serves on the AHS Electronic Media committee and was chosen as an AHS Emerging Leader in the field in 2017. She is also a member of the International Headache Society.

Dr Hindiyeh completed her medical degree at the University of Toledo College of Medicine in Toledo Ohio. Both her internship and neurology residency were completed at the University of California, Irvine, Medical Center, where she was chief resident. She completed her fellowship in headache and facial pain at Stanford University School of Medicine.


Nada Hindiyeh has received consultation fees from Eli Lilly and Lundbed

Sign up for eAlerts or take our quiz first and sign up at the end.